Aurora Burlington’s Fetal Fibronectin Test Priced at $620

The Fetal Fibronectin Test at Aurora Medical Center Burlington is a non-invasive diagnostic procedure priced at $620, used to evaluate the risk of preterm birth in pregnant individuals between 22 and 34 weeks gestation. By detecting fetal fibronectin in vaginal secretions—a protein serving as a marker for potential preterm labor—this test helps clinicians decide on appropriate interventions. The listed fee typically covers the laboratory analysis and specimen collection, but may not include associated charges such as office visits or follow-up care. Patients are advised to request an itemized estimate and clarify with their insurer what costs will be covered prior to testing.

Cost Breakdown

• Test Fee: $620 (includes specimen collection and laboratory processing)
• Potential Additional Costs:
  • Office visit or consultation charges
  • Follow-up appointments or additional monitoring
  • Other laboratory or diagnostic tests if indicated

Associated Costs

• Ultrasound or other prenatal testing if necessary
• Medications or interventions if preterm labor risk is confirmed
• Hospital admission in cases of high-risk results

Insurance & Payment Advice

• Contact your insurance provider before the test to confirm coverage and inquire about your out-of-pocket responsibility.
• Ask for the CPT code associated with the fetal fibronectin test to streamline insurance inquiries.
• Request an itemized estimate from your healthcare provider to be aware of all potential charges.
• If uninsured or facing high out-of-pocket costs, ask about payment plans or financial assistance programs.

Preparation and Recovery Tips

• Avoid using lubricants, creams, or having intercourse for 24 hours before the test, as these may affect results.
• The test is quick and non-invasive, with no recovery time required.
• Discuss any symptoms or concerns with your healthcare provider prior to testing.

Frequently Asked Questions

• What is the fetal fibronectin test used for?
  It helps assess the risk of preterm birth by detecting fetal fibronectin in vaginal secretions, indicating potential early labor.
• How is the test performed?
  A healthcare provider collects a swab sample from the cervix or vagina, which is then analyzed in a lab.
• Does the $620 fee include all related costs?
  The listed fee generally covers the test itself, but additional charges (such as office visits or follow-up care) may apply.
• Will insurance cover the cost of the fetal fibronectin test?
  Coverage varies by plan. Confirm with your insurer before the test, providing them with the specific CPT code for accurate information.
• Are there any risks or side effects?
  The test is non-invasive and generally safe, with minimal to no risk or discomfort.
• How quickly will I get the results?
  Results are often available within a few days, but your provider can give you a specific timeline.
• What happens if my test is positive?
  Your healthcare provider may recommend increased monitoring, medications, or interventions to manage the risk of preterm labor.
• Can I eat or drink before the test?
  Yes, there are no dietary restrictions prior to the test.
• What should I do to prepare for the test?
  Avoid vaginal creams, douching, and intercourse for 24 hours before the test, as these can affect the results.
• How accurate is the fetal fibronectin test?
  The test is a useful tool for assessing risk but is not definitive; your provider will interpret the results in the context of your overall health and pregnancy.

The Fetal Fibronectin Test offered at Aurora Medical Center Burlington, located at 252 McHenry St, Burlington, WI, is a diagnostic service priced at $620. This test is designed to assess the risk of preterm birth by detecting the presence of fetal fibronectin, a protein that acts as a "glue" during pregnancy, helping the amniotic sac to adhere to the lining of the uterus. The presence of fetal fibronectin in vaginal secretions between 22 and 34 weeks of pregnancy can indicate an increased risk of preterm labor. The test is non-invasive and involves collecting a sample from the cervix or vagina, providing valuable information for healthcare providers to make informed decisions about managing a pregnancy at risk of early delivery.

What is the Fetal Fibronectin Test? – The Fetal Fibronectin Test is a diagnostic tool used to assess the risk of preterm birth by detecting the presence of fetal fibronectin in vaginal secretions.

Why is the Fetal Fibronectin Test important? – It helps healthcare providers determine the likelihood of preterm labor, allowing for timely interventions to manage and potentially prevent early delivery.

How is the Fetal Fibronectin Test performed? – The test is non-invasive and involves collecting a sample from the cervix or vagina, which is then analyzed for the presence of fetal fibronectin.

Who should consider getting a Fetal Fibronectin Test? – Pregnant women between 22 and 34 weeks of gestation who are experiencing symptoms of preterm labor or have a history of preterm birth may be advised to undergo this test.

What does a positive Fetal Fibronectin Test result mean? – A positive result indicates an increased risk of preterm labor, prompting healthcare providers to take preventive measures or closely monitor the pregnancy.

Is the Fetal Fibronectin Test covered by insurance? – Coverage for the test may vary depending on the insurance provider and plan, so it’s advisable to check with your insurance company for specific details.

What are the next steps after a positive Fetal Fibronectin Test? – Healthcare providers may recommend additional monitoring, lifestyle modifications, or medical interventions to manage the risk of preterm birth.

Can a negative Fetal Fibronectin Test guarantee no preterm labor? – While a negative result significantly reduces the likelihood of preterm labor, it does not completely eliminate the risk, and ongoing monitoring may still be necessary.